Indaptus Therapeutics Analyst Ratings
Indaptus Therapeutics Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/11/2023 | 442.99% | HC Wainwright & Co. | → $12 | Reiterates | Buy → Buy |
| 08/08/2023 | 442.99% | HC Wainwright & Co. | → $12 | Reiterates | Buy → Buy |
| 05/04/2023 | 442.99% | HC Wainwright & Co. | → $12 | Reiterates | → Buy |
| 03/20/2023 | 442.99% | HC Wainwright & Co. | $15 → $12 | Maintains | Buy |
| 03/08/2023 | 578.73% | HC Wainwright & Co. | → $15 | Reiterates | → Overweight |
| 02/08/2023 | 578.73% | HC Wainwright & Co. | → $15 | Reiterates | → Buy |
| 01/31/2022 | 578.73% | HC Wainwright & Co. | → $15 | Assumes | → Buy |
| 10/19/2021 | 623.98% | Maxim Group | → $16 | Upgrades | Hold → Buy |
| 日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
|---|---|---|---|---|---|
| 2023年08月11日 | 442.99% | HC Wainwright公司 | →$12 | 重申 | 購買→購買 |
| 2023/08/08 | 442.99% | HC Wainwright公司 | →$12 | 重申 | 購買→購買 |
| 05/04/2023 | 442.99% | HC Wainwright公司 | →$12 | 重申 | →購買 |
| 03/20/2023 | 442.99% | HC Wainwright公司 | $15→$12 | 維護 | 買 |
| 03/08/2023 | 578.73% | HC Wainwright公司 | →$15 | 重申 | →超重 |
| 02/08/2023 | 578.73% | HC Wainwright公司 | →$15 | 重申 | →購買 |
| 2022年1月31日 | 578.73% | HC Wainwright公司 | →$15 | 假設 | →購買 |
| 10/19/2021 | 623.98% | Maxim集團 | →$16 | 升級 | 持有→購買 |
What is the target price for Indaptus Therapeutics (INDP)?
Indaptus Treeutics(INDP)的目標價格是多少？
The latest price target for Indaptus Therapeutics (NASDAQ: INDP) was reported by HC Wainwright & Co. on August 11, 2023. The analyst firm set a price target for $12.00 expecting INDP to rise to within 12 months (a possible 442.99% upside). 6 analyst firms have reported ratings in the last year.
HC Wainwright&Co.於2023年8月11日報道了Indaptus治療公司(納斯達克代碼：INDP)的最新目標價。這家分析公司將目標價定為12美元，預計Indp將在12個月內升至(可能上漲442.99%)。6家分析公司在過去一年公佈了評級。
What is the most recent analyst rating for Indaptus Therapeutics (INDP)?
Indaptus Treeutics(INDP)的最新分析師評級是多少？
The latest analyst rating for Indaptus Therapeutics (NASDAQ: INDP) was provided by HC Wainwright & Co., and Indaptus Therapeutics reiterated their buy rating.
對Indaptus治療公司(納斯達克代碼：INDP)的最新分析師評級由HC Wainwright&Co.提供，Indaptus治療公司重申了他們的買入評級。
When is the next analyst rating going to be posted or updated for Indaptus Therapeutics (INDP)?
Indaptus Treeutics(INDP)的下一次分析師評級將於何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Indaptus Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Indaptus Therapeutics was filed on August 11, 2023 so you should expect the next rating to be made available sometime around August 11, 2024.
分析師在進行了廣泛的研究後得出股票評級，其中包括查閱公共財務報表，與Indaptus Treeutics的高管和客戶交談，以及聽取收益電話會議。大多數分析師每三個月就會這樣做一次，所以你每年應該會得到每家公司每家公司的4個評級。Indaptus治療公司的上一次評級是在2023年8月11日提交的，所以你應該預計下一次評級將在2024年8月11日左右提供。
Is the Analyst Rating Indaptus Therapeutics (INDP) correct?
分析師對Indaptus Treeutics(INDP)的評級正確嗎？
While ratings are subjective and will change, the latest Indaptus Therapeutics (INDP) rating was a reiterated with a price target of $0.00 to $12.00. The current price Indaptus Therapeutics (INDP) is trading at is $2.21, which is within the analyst's predicted range.
雖然評級是主觀的，並將發生變化，但最新的Indaptus治療公司(INDP)評級被重申，目標價在0.00美元至12.00美元之間。Indaptus Treateutics(INDP)目前的交易價格為2.21美元，在分析師的預測範圍內。
譯文內容由第三人軟體翻譯。